Fundraising Fox
/Companies
Sign in

Valar Labs

Palo Alto, US · Founded 2021 · Delaware corporation · 30 employees on LinkedIn · 6 known investors

Find your way into Valar Labs

Sign up to see every warm intro you have to Valar Labs

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Valar Labs team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.

AI & Machine LearningHealthtechMedical Devices

Founders & leadership

Valar Labs was founded in 2021 by Anirudh Joshi, Viswesh Krishna, and Damir Vrabac.

AJAnirudh Joshi
Anirudh JoshiFounderAnirudh Joshi is a researcher focused on AI in medicine and the co-founder and CEO of Valar Labs, which builds AI-powered pathology analysis tools to guide cancer treatment decisions for physicians and oncology practices.30 Under 30 2025
VKViswesh Krishna
Viswesh KrishnaFounder30 Under 30 2025
DVDamir Vrabac
Damir VrabacCo-Founder30 Under 30 2025
PR
Pranav RajpurkarFounder

Investors · 6

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50M

How we know: a16z's portfolio · Not right? Tell us

Martin Ventureslisted by Martin VenturesNashville · $2M – $4M

How we know: Martin Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Pear VClisted by Pear VCSan Francisco · $150K – $4M

How we know: funding news · pear.vc · open dataset · 5k.vc investor directory · Not right? Tell us

REMUS Capitallisted by REMUS CapitalBoston · $25K – $20M

How we know: REMUS Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Hummingbird VenturesreportedBrussels · $500K – $10M

How we know: a partner's Signal profile · Not right? Tell us

Funding

SEC filings, press & company announcements

$26.1M disclosed across 2 rounds · 2021–2024

▶$4.1MraisedApr 2022 · 19 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Anirudh Rajiv JoshiExecutive Officer, Director
  • Damir VrabacExecutive Officer, Director
  • Viswesh KrishnaExecutive Officer, Director
Offering amount
$4.1M
Amount sold
$4.1M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

ValoValo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields. It positions itself as a company focused on reshaping how new drugs are discovered.
Valora TherapeuticsValora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications. Its work builds on glycobiology and bioorthogonal chemistry research.
Rupa HealthA platform that enables healthcare providers to order, track, and receive lab test results from multiple laboratory companies through a single dashboard, supporting both in-person and telehealth patients with flexible billing options and EHR integration.
ValotxValoTx develops oncolytic virus-based immunotherapies that combine viral vector technology with peptide vaccination to treat cancer. The company leverages a patented platform to rapidly create personalized and disease-specific immunotherapies targeting multiple cancer types.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
VolastraVolastra Therapeutics is a drug discovery and development company working on novel cancer therapies. Its team spans drug discovery, clinical development, and business strategy to bring new oncology treatments to patients.

Companies working in the same space as Valar Labs.

In the news

Valar Labs Raises $22M in Series A Fundingfinsmes.com · May 2024AI to predict cancer treatment outcomes: Valar Labs $22M Series Atechcrunch.com · May 2024Valar Labs Funding: $22.0M | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Valar Labs do?
Valar Labs develops AI-powered pathology analysis tools to assist physicians in cancer treatment decisions. The company serves hospitals, clinics, and oncology practices by leveraging artificial intelligence to extract diagnostic insights from pathology slides.
Who founded Valar Labs?
Valar Labs was founded by Anirudh Joshi, Viswesh Krishna, Damir Vrabac in 2021.
Who are Valar Labs's investors?
Valar Labs's investors include DCVC (Data Collective), Andreessen Horowitz, Martin Ventures, Pear VC, REMUS Capital, Hummingbird Ventures.
How much funding has Valar Labs raised?
Valar Labs has disclosed $26.1M raised across 2 rounds.
Where is Valar Labs headquartered?
Valar Labs is headquartered in Palo Alto, US.